Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hydbring

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Translational Lung Cancer Research|April 14, 2023
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patientsPer Hydbring
Methods in Molecular Biology (Clifton, N.J.)|January 1, 2022
Concepts and Design of Introducing Synthetic MicroRNAs into Mammalian CellsPer Hydbring
Translational Lung Cancer Research|October 17, 2022
Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinomaPer Hydbring
Translational Lung Cancer Research|August 14, 2023
Targeting gene fusions in non-small cell lung cancer-a ceaseless success story?Per Hydbring
Translational Lung Cancer Research|October 21, 2024
Circulating tumor DNA (ctDNA)-the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?Per Hydbring
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Construction of a Full-Length 3'UTR Reporter System for Identification of Cell-Cycle Regulating MicroRNAsDominika Kaźmierczak, Per Hydbring
F1000Research|March 18, 2014
Clinical applications of microRNAsPer Hydbring, Gayane Badalian-Very
Cancer Research|August 18, 2010
Tipping the balance: Cdk2 enables Myc to suppress senescencePer Hydbring, Lars-Gunnar Larsson
Aging|May 7, 2010
Cdk2: a key regulator of the senescence control function of MycPer Hydbring, Lars-Gunnar Larsson
Frontiers in Immunology|April 22, 2024
Editorial: Immune-mediated damage to the heart and lungs in autoimmune diseasesLingling Wei, Per Hydbring, Li Long
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|April 14, 2023
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patientsPer Hydbring
Methods in Molecular Biology (Clifton, N.J.)|January 1, 2022
Concepts and Design of Introducing Synthetic MicroRNAs into Mammalian CellsPer Hydbring
Translational Lung Cancer Research|October 17, 2022
Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinomaPer Hydbring
Translational Lung Cancer Research|August 14, 2023
Targeting gene fusions in non-small cell lung cancer-a ceaseless success story?Per Hydbring
Translational Lung Cancer Research|October 21, 2024
Circulating tumor DNA (ctDNA)-the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?Per Hydbring
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Construction of a Full-Length 3'UTR Reporter System for Identification of Cell-Cycle Regulating MicroRNAsDominika Kaźmierczak, Per Hydbring
F1000Research|March 18, 2014
Clinical applications of microRNAsPer Hydbring, Gayane Badalian-Very
Cancer Research|August 18, 2010
Tipping the balance: Cdk2 enables Myc to suppress senescencePer Hydbring, Lars-Gunnar Larsson
Aging|May 7, 2010
Cdk2: a key regulator of the senescence control function of MycPer Hydbring, Lars-Gunnar Larsson
Frontiers in Immunology|April 22, 2024
Editorial: Immune-mediated damage to the heart and lungs in autoimmune diseasesLingling Wei, Per Hydbring, Li Long
Pageof 5